Laura Vaingard

Laura Vaingard

Public Policy Expert
Laura Vaingard offers insights on healthcare reform for public policy professionals,  suggesting various interventions government officials can implement nationally to alleviate poor healthcare practices. She advocates for healthcare reform for rural communities and expanded access to mental health services, while also discussing the economics of prescription drug pricing.
Texas Law Enhances Police Response to Mental Health Crises
Public Policy Texas Law Enhances Police Response to Mental Health Crises

Imagine a late-night call to emergency services in a Texas city, where a family member is in the throes of a severe mental health crisis, unaware of their own distress, and refusing help. For too long, law enforcement officers responding to such scenes have been constrained by rigid guidelines,

Can Kardium’s Globe System Redefine AFib Treatment?
Public Policy Can Kardium’s Globe System Redefine AFib Treatment?

Atrial fibrillation (AFib), a heart condition affecting millions globally, disrupts normal heart rhythm and poses significant risks of stroke and heart failure if untreated. Imagine a patient struggling with persistent fatigue and palpitations, seeking a solution that offers not just relief but

Trend Analysis: Vaccine Mandate Rollbacks in Florida
Public Policy Trend Analysis: Vaccine Mandate Rollbacks in Florida

What if a single policy decision could unravel decades of public health achievements, exposing communities to preventable diseases once thought eradicated? This pressing question looms large as Florida proposes a groundbreaking and controversial rollback of all vaccine mandates, including those for

Pulsed Field Ablation Technology – Review
Public Policy Pulsed Field Ablation Technology – Review

Setting the Stage for Cardiac Innovation Imagine a world where millions suffering from irregular heartbeats, particularly atrial fibrillation (AF), can access a treatment that is not only swift but also remarkably safe, transforming the landscape of cardiac care. This condition, affecting countless

Can Pakistan Build a China-Inspired Healthcare System?
Public Policy Can Pakistan Build a China-Inspired Healthcare System?

What if a nation of over 240 million people could transform its crumbling hospitals into centers of cutting-edge care, rivaling global standards? In Pakistan, where public health facilities often struggle with overcrowding and outdated equipment, this vision is no longer just a fantasy. Prime

Mold Toxicity: A Personal Battle and Call for Better Care
Public Policy Mold Toxicity: A Personal Battle and Call for Better Care

In a quiet Miami apartment, what began as a seemingly innocuous move for Ariana Thacker turned into a life-altering health crisis that millions unknowingly face, revealing a hidden public health issue. Subtle hints of trouble, like lingering fatigue and a faint musty odor, were easy to dismiss as

FDA Fast Tracks Stenoparib for Advanced Ovarian Cancer
Public Policy FDA Fast Tracks Stenoparib for Advanced Ovarian Cancer

Introduction to a Critical Health Challenge Imagine a diagnosis that strikes over 19,000 women annually in the United States, often detected at a stage where options are limited and outcomes uncertain, making it a pressing public health concern. Ovarian cancer remains one of the deadliest

CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate
Public Policy CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep background in medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of innovation in the field. Today, we'll

AI as Co-Pilot in Regulatory Medical Writing Webinar
Public Policy AI as Co-Pilot in Regulatory Medical Writing Webinar

Introduction to the Evolving Landscape of Medical Writing Imagine a world where regulatory medical writing, a cornerstone of the pharmaceutical and healthcare industries, achieves unprecedented speed and precision, delivering life-saving therapies to patients faster than ever before. This vision is

FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks
Public Policy FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks

What happens when a long-awaited solution to a debilitating disease turns into a potential threat? In a stunning turn of events, the U.S. Food and Drug Administration (FDA) has suspended the license of Ixchiq, the first chikungunya vaccine approved in the U.S., developed by Valneva, a France-based

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later